| __timestamp | Wave Life Sciences Ltd. | Xenon Pharmaceuticals Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 2395000 | 5903000 |
| Thursday, January 1, 2015 | 9057000 | 2762000 |
| Friday, January 1, 2016 | 393000 | 1114000 |
| Sunday, January 1, 2017 | 79309000 | 25573000 |
| Monday, January 1, 2018 | 134428000 | 6000000 |
| Tuesday, January 1, 2019 | 175431000 | 38845000 |
| Wednesday, January 1, 2020 | 124165000 | 50523000 |
| Friday, January 1, 2021 | 121875000 | 75463000 |
| Saturday, January 1, 2022 | 10114000 | 105767000 |
| Sunday, January 1, 2023 | 9206000 | 167512000 |
Unlocking the unknown
In the ever-evolving landscape of biotechnology, understanding cost structures is crucial for investors and stakeholders. Over the past decade, Xenon Pharmaceuticals Inc. and Wave Life Sciences Ltd. have shown distinct trajectories in their cost of revenue. From 2014 to 2023, Wave Life Sciences experienced a dramatic increase, peaking in 2019 with a cost of revenue nearly 73 times higher than in 2016. This surge reflects their aggressive expansion and investment in research. Conversely, Xenon Pharmaceuticals displayed a more consistent growth pattern, with a notable 184% increase from 2014 to 2023. The year 2023 marked a significant milestone for Xenon, as their cost of revenue reached its highest, indicating robust operational scaling. These trends highlight the dynamic strategies of both companies in navigating the competitive biotech sector.
Cost of Revenue Trends: GSK plc vs Wave Life Sciences Ltd.
Cost of Revenue Comparison: Biogen Inc. vs Xenon Pharmaceuticals Inc.
Analyzing Cost of Revenue: Bio-Techne Corporation and Xenon Pharmaceuticals Inc.
Cost of Revenue Comparison: Bio-Techne Corporation vs Wave Life Sciences Ltd.
Cost Insights: Breaking Down BioMarin Pharmaceutical Inc. and Xenon Pharmaceuticals Inc.'s Expenses
Cost Insights: Breaking Down Sarepta Therapeutics, Inc. and Wave Life Sciences Ltd.'s Expenses
Walgreens Boots Alliance, Inc. vs Xenon Pharmaceuticals Inc.: Efficiency in Cost of Revenue Explored
Cost Insights: Breaking Down Exelixis, Inc. and Wave Life Sciences Ltd.'s Expenses
Cost of Revenue Trends: Amneal Pharmaceuticals, Inc. vs Xenon Pharmaceuticals Inc.
Cost Insights: Breaking Down Xenon Pharmaceuticals Inc. and Vericel Corporation's Expenses
Comparing Cost of Revenue Efficiency: Vericel Corporation vs Wave Life Sciences Ltd.
Cost of Revenue: Key Insights for Wave Life Sciences Ltd. and Celldex Therapeutics, Inc.